The Importance of Genomic Changes of Sars-Cov-2 and Its Comparison With Iranian-Reported Covid-19 Sequencing; Whether Each Country Has to Design Its Treatment and Vaccine Production Publisher



Velayati A¹ ; Farnia P¹ ; Besharati S¹ ; Farnia P¹ ; Ghanavi J¹ Show Affiliations
Source: Biomedical and Biotechnology Research Journal Published:2020

Abstract

Coronavirus (COVID-19), a type of RNA virus, has a positive, single, sense stranded RNA. Studies of coronaviruses have shown high mutations in the virus's RNA. The more the virus infects people, the more the genome will mutate. In addition, evolutionary and genetic studies have the potential to recombine and easily jump from one host to another host. This means flexibility to adapt to new conditions and proliferation in new host cells. Examination of the hosts of this virus shows their extent. Studies show that the virus closely resembles hosts such as bats and pangolins. Genomic studies on severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and bat coronavirus (RaTG13) showed 96.2% genetic similarity although there are differences in the nucleotides of different hosts. The importance of examining mutated areas in coronaviruses for diagnosis and treatment is necessary because molecular methods such as RT-PCR, although having a specific probe, may not cause a connection between the primer and the specific probe and cause a false-negative response be reported. This issue has led various countries to sequence SARS-CoV-2 for their own countries, eventually leading to the identification of specific drugs and vaccines for their country. © 2020 Biomedical and Biotechnology Research Journal (BBRJ) | Published by Wolters Kluwer-Medknow.